Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Boston Life Science Leasing Activity Normalizes to Pre-Pandemic Levels
Leasing activity in Boston’s life science market has started to normalize after the pandemic, according to second-quarter 2023 life science statistics from Cushman & Wakefield.
While leasing activity slowed in the second quarter, C&W expects it to rebound in the coming quarters as Greater Boston continues to be a thriving market for life science companies. Currently, 14.7% of the region’s 35.5 million square feet of lab inventory is available for lease, with overall vacancy at 14.3%, higher than historical averages.
Despite the slowdown, nearly 1.2 million square feet of new lab space has been delivered in six developments since the start of 2023, with a leasing rate of 37.9%. Preleasing for under-construction inventory stands at 35.3% in Greater Boston, with Cambridge and Boston’s Central Business District performing well.
- ◦Lease